Literature DB >> 2789233

Neopterin and alpha and beta interleukin-1 levels in sera of patients with human immunodeficiency virus infection.

M M Reddy1, M H Grieco.   

Abstract

Levels of neopterin and alpha and beta interleukin-1 (IL-1) in sera of normal controls, asymptomatic intravenous drug abusers, homosexuals, and patients with lymphadenopathy or acquired immunodeficiency syndrome were measured. Neopterin levels were elevated in the sera of human immunodeficiency virus (HIV)-seronegative intravenous drug abusers and homosexuals, as well as in the sera of HIV-seropositive patients. Alpha IL-1 was the most predominant form of IL-1 found in the sera of all groups, and its level in HIV-seronegative intravenous drug abusers was elevated compared with the level in controls, whereas its levels in asymptomatic HIV-seropositive intravenous drug abusers and asymptomatic HIV-seronegative and HIV-seropositive homosexuals were decreased relative to the level in controls. Beta IL-1 levels in sera in all groups were not significantly different from the control value, except for the HIV-seropositive homosexual group; in this group the beta IL-1 level was significantly decreased compared with the control value.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789233      PMCID: PMC267709          DOI: 10.1128/jcm.27.9.1919-1923.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

Review 1.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection.

Authors:  D Fuchs; A Hausen; G Reibnegger; E R Werner; M P Dierich; H Wachter
Journal:  Immunol Today       Date:  1988-05

2.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

3.  Abstracts for the VI International Symposium on Human Purine and Pyrimidine Metabolism. Hakone, Japan, July 17-July 21, 1988.

Authors: 
Journal:  Pediatr Res       Date:  1988-07       Impact factor: 3.756

4.  Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol.

Authors:  D Fuchs; B Unterweger; A Hausen; G Reibnegger; E R Werner; P Hengster; H Hinterhuber; M P Dierich; H Wachter; W A Blattner
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

5.  Predicting who will progress to AIDS.

Authors:  A R Moss
Journal:  BMJ       Date:  1988-10-29

6.  Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy.

Authors:  E DeStefano; R M Friedman; A E Friedman-Kien; J J Goedert; D Henriksen; O T Preble; J A Sonnabend; J Vilcek
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

Review 7.  The natural history of human immunodeficiency virus infection.

Authors:  A R Lifson; G W Rutherford; H W Jaffe
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

8.  Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS).

Authors:  A S Fauci
Journal:  Clin Res       Date:  1984-12

9.  Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations.

Authors:  M M Reddy; S J Sorrell; M Lange; M H Grieco
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

10.  Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Lange; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  8 in total

1.  Interleukin-1 concentration in patients infected with human immunodeficiency virus.

Authors:  R J Leeming
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

2.  Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.

Authors:  Carey L Shive; Joseph C Mudd; Nicholas T Funderburg; Scott F Sieg; Benjamin Kyi; Doug A Bazdar; Davide Mangioni; Andrea Gori; Jeffrey M Jacobson; Ari D Brooks; Jeffrey Hardacre; John Ammori; Jacob D Estes; Timothy W Schacker; Benigno Rodriguez; Michael M Lederman
Journal:  J Infect Dis       Date:  2014-02-28       Impact factor: 5.226

Review 3.  Cytokines and T-Cell Homeostasis in HIV Infection.

Authors:  Michael L Freeman; Carey L Shive; Thao P Nguyen; Souheil-Antoine Younes; Soumya Panigrahi; Michael M Lederman
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

Review 4.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

5.  Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.

Authors:  Anupa Kamat; V Ravi; Anita Desai; P Satishchandra; K S Satish; Mahendra Kumar
Journal:  J Neurovirol       Date:  2008-11-22       Impact factor: 2.643

Review 6.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

7.  Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states.

Authors:  L Bélec; D Meillet; A Hernvann; G Grésenguet; R Gherardi
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

8.  Effect of a recombinant HIV gp160 vaccine on monokine production.

Authors:  D P Dooley; R A Cox; D J Looney
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.